Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

covid PPE surplus

COVID protective gear expires, piles up—and goes to waste

What happens when hospitals en masse stock up on supplies to withstand a health crisis of unknown duration?

the words "FDA recall" on a board

FDA announces Class I recall of 150 MRI scanners due to risk of explosion

Just one explosion has been reported due to this issue, but the risk is considered severe enough to require a recall. 

Peter Moffatt, RBMA president-elect, discusses biggest issues facing radiology practices at RSNA 2023. #RBMA #RSNA #Radiology #CMScuts

Navigating the crucial challenges in radiology practice management

RBMA President-elect Pete Moffatt discusses how to contend with challenges such as staff shortages and reimbursement issues.

healthcare value value-based care money dollar

Advocates criticize unfunded transparency mandate on imaging providers in recently passed legislation

The Lower Costs, More Transparency Act requires radiologists to publicly list prices for certain "shoppable" services.

Thumbnail

Physician groups press Congress to address radiologist pay cut in early 2024

“We write to emphasize the urgent need for Congress to take action," the Medical Group Management Association wrote to House and Senate leaders Dec. 19. 

maya kowalski johns hopkins trial

Did ‘Maya’ juror call Hopkins witness a Nazi—or did Hopkins lawyers smear a good juror?

To their reasons for seeking a retrial in the Maya Kowalski case, attorneys for Johns Hopkins All Children’s Hospital in Florida have added a juror’s possibly mischievous and bias-revealing courtroom notes.

Thumbnail

Feds issue final rule setting No Surprises Act IDR administrative fee at $115

This action comes in response to a lawsuit filed by the Texas Medical Association earlier this year, challenging a 600% increase to this charge.

Thumbnail

Pharmacy firm eyes 2024 rollout of 1st targeted PET imaging agent for kidney cancer

Telix Pharmaceuticals recently submitted its license application to the FDA for the investigational positron emission tomography agent TLX250-CDx (Zircaix).